Cargando…
The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients
The tumor burden (TB) is significantly related to the severity of cytokine release syndrome (CRS) caused by CAR-T cells, but its correlation with therapeutic efficacy has not been systematically studied. This study focused on the effects of the TB level on both the safety and efficacy of ssCART-19 a...
Autores principales: | Li, Minghao, Xue, Sheng-Li, Tang, Xiaowen, Xu, Jiayu, Chen, Suning, Han, Yue, Qiu, Huiying, Miao, Miao, Xu, Nan, Tan, Jingwen, Kang, Liqing, Yu, Zhou, Lou, Xiaoyan, Xu, Yang, Chen, Jia, Yan, Zhiqiang, Feng, Weixing, Wu, Depei, Yu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748521/ https://www.ncbi.nlm.nih.gov/pubmed/35013456 http://dx.doi.org/10.1038/s41598-021-04296-3 |
Ejemplares similares
-
The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell Transplantation
por: Shan, Meng, et al.
Publicado: (2022) -
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells
por: Tan, Jingwen, et al.
Publicado: (2022) -
Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells
por: Yan, Lingzhi, et al.
Publicado: (2019) -
Allogeneic hematopoietic stem cell transplantation from non-sibling 10/10 HLA-matched related donors: a single-center experience
por: Shen, Yaoyao, et al.
Publicado: (2021) -
Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes
por: Kang, Liqing, et al.
Publicado: (2020)